Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Eric Horwitz

Center AffiliationsMolecular Therapeutics

Publications (211) (print view)

no pagination
Chism DB, Hanlon AL, Horwitz EM, Feigenberg SJ, Pollack A. A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy. International Journal of Radiation Oncology Biology Physics. 2004 Jun;59(2):380-5.
Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E. Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. Journal of Clinical Oncology. 2004 Jul;22(14):2856-64.
Hanlon AL, Horwitz EM, Hanks GE, Pollack A. Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 2004 Jan;58(1):43-52.
Horwitz EM, Feigenberg SJ, Pollack A, Hanks GE, Uzzo RG. Androgen suppression plus radiation therapy for prostate cancer. JAMA-Journal of the American Medical Association. 2004 Nov 03;292(17):2084-5.
Horwitz EM, Feigenberg SJ, Uzzo RG. The treatment of non-metastatic prostate cancer with external beam radiation therapy. Minerva Urologica e Nefrologica. 2004 Jun;56(2):173-88.
Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A. The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer. Cancer. 2004 Feb;100(3):538-43.
Kramer NM, Horwitz EM, Uzzo RG, Hanlon AL, Hanks GE. Matched-cohort analysis of patients with prostate cancer followed with observation or treated with three-dimensional conformal radiation therapy. BJU international. 2004 Jul;94(1):59-62.
Manne S, Babb J, Pinover W, Horwitz E, Ebbert J. Psychoeducational group intervention for wives of men with prostate cancer. Psycho-Oncology. 2004 Jan;13(1):37-46.
Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Uzzo RG, Hanks GE. Prostate cancer radiotherapy dose response: An update of the fox chase experience. Journal of Urology. 2004 Mar;171(3):1132-6.
Ridge JA, Glisson BS, Horwitz E, Meyers MO. Head and neck tumours. In: Pazur R, Coia LR, Hoskins WJ, Wagman LD, editors. Cancer Management: A Multidisciplinary Approach. Manhasset: CMP Healthcare Media; 2004. p. 39-85.
Uzzo RG, Brown JG, Horwitz EM, Hanlon A, Mazzoni S, Konski A, Greenberg RE, Pollack A, Kolenko V, Watkins-Bruner D. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer. BJU international. 2004 May;93(7):955-60.
Uzzo RG, Cairns P, Dulin N, Horwitz EM, Pollack A, Kolenko V. Tumor resistance to apoptosis: Mechanisms of evasion and implications for radiation and chemotherapeutic strategies. Cancer Immunotherapy at the Crossroads. 2004 Jan;:215-34.
Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE, Pollack A. Positive prostate biopsy laterality and implications for staging. Urology. 2003 Aug;62(2):298-303.
Chism DB, Hanlon AL, Horwitz EM, Feigenberg SJ, Pollack A. A comparison of the single vs. double high-risk factor stratification systems for prostate cancer treated radiotherapy without androgen deprivation. Int J Radiat Oncol Biol Phys. 2003 Oct;57(2 Suppl):S270.
Chism DB, Hanlon AL, Troncoso P, Al-Saleem T, Horwitz EM, Pollack A. The Gleason score shift: score four and seven years ago. Int J Radiat Oncol Biol Phys. 2003 Aug;56(5):1241-7.
Chism DB, Horwitz EM, Hanlon AL, Pinover WH, Mitra RK, Hanks GE. Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement. Int J Radiat Oncol Biol Phys. 2003 Jan;55(1):71-7.
Diefenbach MA, Hamrick N, Uzzo R, Pollack A, Horwitz E, Greenberg R, Engstrom PF. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. Journal of Urology. 2003 Jul;170(1):166-9.
Feigenberg SJ, Hanlon AL, Horwitz EM, Pollack A. Androgen deprivation increases late morbidity in prostate cancer patients treated with 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2003 Oct;57(2 Suppl):S176.
Hammond E, Berkey BA, Fu KK, Trotti A, Meredith RF, Jones CU, Byhardt R, Horwitz EM, Ang KK, Radiation Therapy Oncology G. p105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: A clinical/laboratory correlative analysis of RTOG-9003. International Journal of Radiation Oncology Biology Physics. 2003 Nov;57(3):683-92.
Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02. Journal of Clinical Oncology. 2003 Nov;21(21):3972-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Eric Horwitz Sparkline Graph

Graph Interactions


Similar Investigators:

Keywords (MeSH):

Last updated on Friday, February 02, 2018